[go: up one dir, main page]

BR9913337A - Derivados tan-1057 - Google Patents

Derivados tan-1057

Info

Publication number
BR9913337A
BR9913337A BR9913337-7A BR9913337A BR9913337A BR 9913337 A BR9913337 A BR 9913337A BR 9913337 A BR9913337 A BR 9913337A BR 9913337 A BR9913337 A BR 9913337A
Authority
BR
Brazil
Prior art keywords
derivatives
tan
man
animals
diseases
Prior art date
Application number
BR9913337-7A
Other languages
English (en)
Inventor
Michael Brands
Mazen Es-Sayed
Dieter Haebich
Siegfried Raddatz
Joachim Krueger
Rainer Endermann
Reinhold Gahlmann
Hein-Peter Kroll
Frank-Ulrich Geschke
Armin De Meijere
Vladimir N Belov
Victor Sokolov
Sergej Kozhushkov
Markus Kordes
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9913337A publication Critical patent/BR9913337A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS TAN-1057"<D>. A invenção refere-se a novos derivados de substâncias naturais, processos para a sua preparação, composições farmacêuticas que as abrangem, bem como seu emprego no tratamento de doenças no homem ou nos animais.
BR9913337-7A 1998-08-27 1999-08-20 Derivados tan-1057 BR9913337A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19838998A DE19838998A1 (de) 1998-08-27 1998-08-27 Neue Naturstoffderivate
PCT/EP1999/006124 WO2000012484A1 (de) 1998-08-27 1999-08-20 Tan-1057 derivate

Publications (1)

Publication Number Publication Date
BR9913337A true BR9913337A (pt) 2001-05-15

Family

ID=7878913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913337-7A BR9913337A (pt) 1998-08-27 1999-08-20 Derivados tan-1057

Country Status (25)

Country Link
US (1) US6617332B1 (pt)
EP (1) EP1117652B1 (pt)
JP (1) JP4533535B2 (pt)
KR (1) KR20010099629A (pt)
CN (1) CN1324348A (pt)
AT (1) ATE267816T1 (pt)
AU (1) AU759618B2 (pt)
BG (1) BG105275A (pt)
BR (1) BR9913337A (pt)
CA (1) CA2342102C (pt)
DE (2) DE19838998A1 (pt)
EE (1) EE200100125A (pt)
ES (1) ES2219105T3 (pt)
HK (1) HK1041884A1 (pt)
HR (1) HRP20010135A2 (pt)
HU (1) HUP0103316A3 (pt)
ID (1) ID28365A (pt)
IL (1) IL141325A0 (pt)
NO (1) NO20010940L (pt)
NZ (1) NZ510153A (pt)
PL (1) PL346143A1 (pt)
SK (1) SK2622001A3 (pt)
TR (1) TR200100637T2 (pt)
WO (1) WO2000012484A1 (pt)
ZA (1) ZA200101038B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113008A1 (en) * 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
US20040204404A1 (en) * 2002-09-30 2004-10-14 Robert Zelle Human N-type calcium channel blockers
KR20100101073A (ko) * 2007-12-20 2010-09-16 닥터 레디스 레보러터리즈 리미티드 시타글립틴 및 약제학적으로 허용되는 그의 염의 제조 방법
CN102548956B (zh) 2009-10-15 2014-05-14 国立大学法人德岛大学 二乙烯三胺五醋酸衍生物的制造方法及二乙烯三胺五醋酸衍生物
CA2777741A1 (en) * 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
WO2011047320A2 (en) 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
CN105646370A (zh) * 2009-10-16 2016-06-08 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
MX349718B (es) 2009-10-16 2017-08-10 Melinta Therapeutics Inc Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
EP2697229B1 (en) 2011-04-15 2018-04-04 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
RU2475479C1 (ru) * 2011-12-23 2013-02-20 Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) Вазоконстрикторное средство
AU2014315045A1 (en) 2013-09-09 2016-03-24 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
JP2016536338A (ja) 2013-09-09 2016-11-24 メリンタ セラピューティクス，インコーポレイテッド 抗微生物化合物ならびにそれの製造方法および使用方法
CA2979342A1 (en) 2015-03-11 2016-09-15 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CN110312722A (zh) 2016-05-06 2019-10-08 生物验证系统股份公司 抗微生物剂及其制备和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途
EP1003727A1 (en) * 1997-08-07 2000-05-31 Research Corporation Technologies Antibiotic for methicillin resistant bacteria

Also Published As

Publication number Publication date
CA2342102C (en) 2008-10-28
WO2000012484A1 (de) 2000-03-09
ZA200101038B (en) 2002-02-07
JP4533535B2 (ja) 2010-09-01
US6617332B1 (en) 2003-09-09
ES2219105T3 (es) 2004-11-16
DE19838998A1 (de) 2000-03-09
BG105275A (en) 2001-11-30
ATE267816T1 (de) 2004-06-15
EP1117652A1 (de) 2001-07-25
EE200100125A (et) 2002-06-17
TR200100637T2 (tr) 2001-10-22
NO20010940L (no) 2001-04-23
NO20010940D0 (no) 2001-02-23
EP1117652B1 (de) 2004-05-26
HK1041884A1 (zh) 2002-07-26
CN1324348A (zh) 2001-11-28
NZ510153A (en) 2002-12-20
HUP0103316A3 (en) 2002-06-28
DE59909607D1 (de) 2004-07-01
ID28365A (id) 2001-05-17
IL141325A0 (en) 2002-03-10
AU759618B2 (en) 2003-04-17
CA2342102A1 (en) 2000-03-09
KR20010099629A (ko) 2001-11-09
SK2622001A3 (en) 2001-11-06
PL346143A1 (en) 2002-01-28
HRP20010135A2 (en) 2002-02-28
JP2002523496A (ja) 2002-07-30
AU1009900A (en) 2000-03-21
HUP0103316A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
BR9915208A (pt) Preparado farmacêutico de moxifloxacina
BR9913337A (pt) Derivados tan-1057
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
PA8657201A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
BR9808255A (pt) Amidas de ácido aminossalicìlico substituìdas com efeito fungicida e produtos intermediários para sua preparação.
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
TR200101649T2 (tr) Piperazin türevleri.
FR2755965B1 (fr) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
BR0012291A (pt) Fenoxifluorpirimidinas
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
BR0115883A (pt) Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5 A 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.